New methodologogic approaches to the management of antituberculous service

A. Svistelnic, V. Krasnov, I. Kalachov, L. Pogozheva, D. Stepanov (Novosibirsk, Russia)

Source: Annual Congress 2003 - Control of tuberculosis
Session: Control of tuberculosis
Session type: Oral Presentation
Number: 2459
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Svistelnic, V. Krasnov, I. Kalachov, L. Pogozheva, D. Stepanov (Novosibirsk, Russia). New methodologogic approaches to the management of antituberculous service. Eur Respir J 2003; 22: Suppl. 45, 2459

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New perspectives in MDR-TB management
Source: International Congress 2016 – China Session II
Year: 2016


New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002

New guidelines to manage MDR-TB
Source: School Course 13
Year: 2013


New experiences from global use of new tools in TB management and control
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013



New perspectives in PGD prevention and treatment
Source: School Course 2012 - Lung Transplantation
Year: 2012


Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012


New antibiotics into clinical practice
Source: Annual Congress 2004 - PG18 - Childhood pneumonia after the turn of the new millennium
Year: 2004


Management of drug resistant pulmonary TB. New problems and perspectives
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


New anti-tuberculosis drugs and regimens: 2015 update
Source: ERJ Open Res 2015; 1: 00010-2015
Year: 2015



New anti-tuberculosis drugs for special populations: a difficult-to-address issue
Source: Eur Respir J 2016; 48: 957-958
Year: 2016


New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017


Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012


Better diagnostics for targeted antibiotic therapy
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


Excellency of anti-tuberculosis primary care: an evidence-based medicine challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 142s
Year: 2005

Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008


New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017